Results 101 to 110 of about 13,568,693 (193)

Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model

open access: yesTranslational Psychiatry
Major depressive disorder (MDD) remains a leading cause of disability worldwide, with current treatments limited by delayed onset and low efficacy. The serotonergic psychedelic N,N-dimethyltryptamine (DMT) has shown rapid antidepressant effects in early ...
Rafael V. Lima da Cruz   +5 more
doaj   +1 more source

Pharmacology and Therapeutic Potential of N,N-Dimethyltryptamine: Ischemia-Related Application

open access: yes
This thesis explores the therapeutic potential of N,N-Dimethyltryptamine (DMT), a naturally occurring psychedelic compound known for its intense but short-lasting psychoactive effects.
Aghapour Olilo, Benyamin
core  

Study of the indoleamine 2,3-dioxygenase inhibitory action by tryptamine (TRY) and N,N-dimethyltryptamine (DMT)

open access: yes, 2012
A enzima indolamina 2,3-dioxigenase (IDO) é responsável pela degradação de triptofano (TRP) pela via das quinureninas. O aumento da expressão de IDO é a grande responsável pela resposta de tolerância imunológica e pode ser induzida por IFN-γ e ...
Melissa Cavalheiro Tourino   +1 more
core   +1 more source

Parapsychology, N, N-Dimethyltryptamine and the Pineal Gland

open access: yes, 2019
In the last decades, one of the psychedelic substances which has gained high attention for its implications in several para-psychological phenomena (including out-of-body states, deep changes in sensory perception, mood, and thought, travels in ...
Bragazzi, Nicola Luigi   +8 more
core  

Predicting drug–drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling

open access: yesFrontiers in Molecular Biosciences
IntroductionAyahuasca is a psychedelic preparation containing N,N-dimethyltryptamine (DMT) and the β-carboline harmine (HRM), a reversible monoamine oxidase A inhibitor that enables DMT oral bioavailability.
Gabriella de Souza Gomes Ribeiro   +15 more
doaj   +1 more source

Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults

open access: yesScientific Reports
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a naturally occurring psychedelic tryptamine. Plants containing 5-MeO-DMT have been used throughout history, and in recent years both synthetic and toad-derived 5-MeO-DMT use is being increasingly reported ...
Anna O. Ermakova   +3 more
doaj   +1 more source

Time-resolved Neural and Experience Dynamics of Medium- and High-dose N,N-Dimethyltryptamine (DMT)

open access: yesJournal of Cognitive Neuroscience
Abstract N,N-dimethyltryptamine (DMT) is a fast-acting psychedelic drug that induces a radical reorganization of conscious contents and brain dynamics. However, our understanding of how brain dynamics support psychedelic-induced conscious states remains unclear.
Lewis-Healey, Evan   +9 more
openaire   +3 more sources

Safety and tolerability profile of N,N-Dimethyltryptamine: a systematic review of clinical trials

open access: yes
N,N-Dimethyltryptamine (DMT) is presently emerging as a candidate in clinical trials aimed at addressing treatment-resistant depression. This condition is characterized by its chronic and incapacitating nature, featuring heightened severity and prolonged
Wiesław Jerzy Cubała   +2 more
core   +1 more source

Vigilance state dissociation induced by 5-MeO-DMT in mice

open access: yesCommunications Biology
Psychedelics lead to profound changes in subjective experience and behaviour, which are typically conceptualised in psychological terms rather than corresponding to an altered brain state or a distinct state of vigilance.
Benjamin J. B. Bréant   +7 more
doaj   +1 more source

Human psychopharmacology of N,N-dimethyltryptamine

open access: yes, 1996
We generated dose-response data for the endogenous and ultra-short-acting hallucinogen, N,N-dimethyltryptamine (DMT), in a cohort of experienced hallucinogen users, measuring multiple biological and psychological outcome measures.
Strassman, Rick J
core  

Home - About - Disclaimer - Privacy